Probing the Binding of Interleukin-23 to Individual Receptor Components and the IL23 Heteromeric Receptor Complex in Living Cells Using NanoBRET
Charles S. Lay(University of Nottingham), Stephen John Hill(University of Nottingham), Angela Bridges(GlaxoSmithKline (United Kingdom)), Peter D. Craggs(GlaxoSmithKline (United Kingdom)), Zoja Soloviev(GlaxoSmithKline (United Kingdom)), Stephen J. Briddon(University of Nottingham), Joëlle Goulding(University of Nottingham)
Cited by 3
Related Papers
BET Inhibition Silences Expression of MYCN and BCL2 and Induces Cytotoxicity in Neuroblastoma Tumor Models
|PLoS ONE|2013|205
The p85 Subunit of Phosphatidylinositol 3-Kinase Associates with the Fc Receptor γ-Chain and Linker for Activitor of T Cells (LAT) in Platelets Stimulated by Collagen and Convulxin
|Journal of Biological Chemistry|1998|145
Quantitative analysis of the formation and diffusion of A <sub>1</sub> -adenosine receptor-antagonist complexes in single living cells
|Proceedings of the National Academy of Sciences|2004|117
Pharmacology under the microscope: the use of fluorescence correlation spectroscopy to determine the properties of ligand–receptor complexes
|Trends in Pharmacological Sciences|2007|108
Fragment Screening at Adenosine-A3 Receptors in Living Cells Using a Fluorescence-Based Binding Assay
|Chemistry & Biology|2012|96